MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/cns.14696

Медицинская библиотека · CNS neuroscience & therapeutics · 2024

AZD1390, an ataxia telangiectasia mutated inhibitor, attenuates microglia-mediated neuroinflammation and ischemic brain injury.

Lan Zhen, Qu Long-Jie, Liang Ying, Chen Li-Qiu, Xu Shuai, Ge Jian-Wei, Xue Zhi-Wei, Bao Xin-Yu, Xia Sheng-Nan, Yang Hai-Yan, Huang Jing, Xu Yun, Zhu Xiao-Lei

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

AIMS: Excessive neuroinflammation mediated mainly by microglia plays a crucial role in ischemic stroke. AZD1390, an ataxia telangiectasia mutated (ATM) specific inhibitor, has been shown to promote radio-sensitization and survival in central nervous system malignancies, while the role of AZD1390 in ischemic stroke remains unknown.

METHODS

Real-time PCR, western blot, immunofluorescence staining, flow cytometry and enzyme-linked immunosorbent assays were used to assess the activation of microglia and the release of inflammatory cytokines. Behavioral tests were performed to measure neurological deficits. 2,3,5-Triphenyltetrazolium chloride staining was conducted to assess the infarct volume. The activation of NF-κB signaling pathway was explored through immunofluorescence staining, western blot, co-immunoprecipitation and proximity ligation assay.

RESULTS

The level of pro-inflammation cytokines and activation of NF-κB signaling pathway was suppressed by AZD1390 in vitro and in vivo. The behavior deficits and infarct size were partially restored with AZD1390 treatment in experimental stroke. AZD1390 restrict ubiquitylation and sumoylation of the essential regulatory subunit of NF-κB (NEMO) in an ATM-dependent and ATM-independent way respectively, which reduced the activation of the NF-κB pathway.

CONCLUSION

AZD1390 suppressed NF-κB signaling pathway to alleviate ischemic brain injury in experimental stroke, and attenuated microglia activation and neuroinflammation, which indicated that AZD1390 might be an attractive agent for the treatment of ischemic stroke.

Для цитирования: Lan Zhen, Qu Long-Jie, Liang Ying, Chen Li-Qiu, Xu Shuai, Ge Jian-Wei, Xue Zhi-Wei, Bao Xin-Yu, Xia Sheng-Nan, Yang Hai-Yan, Huang Jing, Xu Yun, Zhu Xiao-Lei. AZD1390, an ataxia telangiectasia mutated inhibitor, attenuates microglia-mediated neuroinflammation and ischemic brain injury.. CNS neuroscience & therapeutics. 2024. DOI: 10.1111/cns.14696.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.